Market Intelligence

NAMS NewAmsterdam Pharma Company NV Ordinary Shares reports widerthanexpected Q4 2025 losses stock dips 125 as revenue halves yearoveryear YCY AA Mission acquisition vehicle seeks targets as it builds war chest for next deal LTM LATAM posts marginal Q4 profit but shares decline 1 as investors await revenue clarity Should I buy Argo Blockchain ARBK stock right now Argo Blockchain posts 019 loss 485M revenue Is CarlylePrefD CCID stock creating a bullish pattern CarlylePrefD reports 44 EPS miss vs consensus Contango ORE CTGO Stock Fast Summary 160 20260420 PRHIZ Presurance notches 198 percent EPS surprise for Q1 2024 stock price stays flat today Chinas Invisible Hand Raises Questions About Global Oil Market Distortions National NRC Earnings Outlook Key Metrics for Q1 2026 Caesars CZR Q1 2026 Earnings Miss EPS 048 vs 024 Expected Historic Fed Overlap Powell and Warsh Set for First Joint FOMC Meeting in June Target Boosts Physical Retail Investment with Major Changes Across 130 US Stores Novo NVO Stock Today Unchanged at 4428 Key Levels 20260519 Retail Sales Surge Beyond Expectations in February Consumer Resilience Signals Economic Strength SpaceX Scrubs Starship Test Flight Targets Friday for Debut of Upgraded V3 Rocket SpaceXs Potential SP Sector Classification Rockets Satellites AI and Data Centers Standard Chartered to Cut Over 15 of Corporate Functions Roles by 2030 in Efficiency Drive Oil Prices Slide as USIran Talks Show Progress but Key Issues Remain Meta Settles Social Media Addiction Lawsuit with US School District Potentially Impacting Over 1200 Similar Claims ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise TEVA Q1 2026 Earnings EPS Beats Estimates by 878 as Generic Drugmaker Posts Strong Quarter TG Therapeutics Q1 2026 Earnings EPS Misses Expectations Despite Stock Gain DIOD Q1 2026 Earnings Strong EPS Surprise of 27 Drives Stock Higher GSAT Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Investment Period Gravity Co GRVY Edges Higher Amid Consolidation Near Resistance Level Jena Acquisition Corporation II JENA Holds Steady Near Resistance as SPAC Market Watches for Catalysts Bridgewater Bancshares BWB Edges Higher Holds Above Key Support Amid Consolidation Contineum Therapeutics CTNM Retreats 108 Key Support Level in Focus Jupiter Neurosciences JUNS Slips 328 as Shares Test Critical Support at 022 Nurix Therapeutics NRIX Edges Higher Consolidating Near Support at 1772 RBIs 25Bps Rate Cut May Signal Shift Away from InflationFirst Stance Nomura Suggests Pam Bondi Acknowledges Errors in Epstein Files Release During Congressional Testimony